Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a diversified line of healthcare products including: drugs, nutritional products, diabetes monitoring devices and diagnostics.
All pharmaceutical companies face the inevitable patent expirations and the ensuing generic competition. However, ABT’s product pipeline includes potential significant launches in the medical device and pharmaceutical areas. With its strong financials and excellent management team, ABT is in a position to continue its growth and to generate strong returns. I will continue to add to my position while it is trading below my buy price of $61.24 and as my allocation allows.
Source: Dividends Value
Related Articles:
Dividend Growth Stocks News
- The Smartest Dividend Stocks to Buy With $1,000 Right Now - The Motley Fool - 5/23/2025
- 3 UK Dividend Stocks To Enhance Your Portfolio - Yahoo Finance - 5/23/2025
- 3 Top Dividend Stocks to Maximize Your Retirement Income - Yahoo Finance - 5/22/2025
- Dividend stocks: Infosys, ITC, Trident, 17 others to go ex-date next week - Business Standard - 5/23/2025
- 3 Asian Dividend Stocks Yielding Up To 4.3% - Yahoo Finance - 5/23/2025
- AFLAC Incorporated (AFL) Dividend Stock Analysis - 5/23/2025
- Automatic Data Processing Inc. (ADP) Dividend Stock Analysis - 5/16/2025
- Air Products and Chemicals Inc. (APD) Dividend Stock Analysis - 5/9/2025
- Waste Management, Inc. (WM) Dividend Stock Analysis - 5/2/2025
- Wal-Mart Stores, Inc. (WMT) Dividend Stock Analysis - 4/25/2025
Stock Analysis: Abbott Laboratories (ABT)
Posted by D4L | Thursday, May 06, 2010 | ArticleLinks | 0 comments »________________________________________________________________
Subscribe to:
Post Comments (Atom)
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.